- Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Olatec Therapeutics initiates enrolment in oral drug trial for Covid-19

Dapansutrile can potentially hinder IL 1β production to stop progression to cytokine storm. Credit: TheDigitalArtist on Pixabay.